Imedd Inc

Sutro Biopharma, Inc. is a public biotechnology company based in South San Francisco, California, specializing in clinical stage drug discovery, development, and manufacturing. Utilizing its innovative XpressCF platform, the company focuses on creating protein therapeutics for cancer and autoimmune disorders, including cytokine-based immune-oncology therapeutics and bispecific antibodies. The company's product candidates, STRO-001 and STRO-002, are antibody-drug conjugates designed to target specific cancer markers such as CD74 and folate receptor-alpha, offering promising treatment options for patients with multiple myeloma, non-Hodgkin lymphoma, ovarian, and endometrial cancers. Generated from their website's infomation

Codexis is one of the leaders in the development of innovative bio-based solutions for pharmaceutical chemical process development and manufacturing. The company s unique protein and strain engineering technology platform creates superior biological catalysts either enzymes or fermentation strains crafted specifically for cutting-edge chemical processes that can enable pharmaceutical process development, shorten process development timelines and dramatically improve existing manufacturing processes. Codexis has more than 12 strategic alliances, including a major collaboration with Pfizer, and more than 20 products and processes in development internally and at leading worldwide life sciences companies. It began operations as an independent company in 2002. Codexis is headquartered in Redwood City, Calif.

Catalyst Biosciences is a biopharmaceutical company based in South San Francisco, CA, specializing in the development of novel therapies for hemophilia and other rare bleeding disorders. The company focuses on utilizing its proprietary protease engineering platform to create next-generation coagulation factors that aim to improve the lives of patients with these conditions. Generated from their business information